Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #264018 on Avid Bioservices Inc (CDMO)
biopharm
05/21/16 8:21 PM
#264618 RE: biopharm #264018
..Adam17 with direct links to exposure of flipped PS...and iRhoms 1 and 2 are essential upstream regulators of ADAM17-dependent EGFR signaling
Breaking down cancer cell defenses Inhibiting membrane enzyme may make some cancer cells more vulnerable to chemotherapy Date: May 21, 2016 Source: University of Pennsylvania School of Medicine Summary: The mistaken activation of certain cell-surface receptors contributes to a variety of human cancers. Knowing more about the activation process has led researchers to be able to induce greater vulnerability by cancer cells to an existing first-line treatment for cancers (mainly lung) driven by a receptor called EGFR. The mistaken activation of certain cell-surface receptors contributes to a variety of human cancers. ... .. https://www.sciencedaily.com/releases/2016/05/160521071209.htm